Upcoming Events

Latest News

  • Legant_Headshot_Cropped-1

    Legant Named 2019 Packard Fellow

    The David and Lucile Packard Foundation announced the 2019 class of Packard Fellow for Science and Engineering, including Wesley Legant, PhD, in the biomedical engineering and pharmacology departments. Read article here

  • Wesley and Won

    Wesley Legant, Hyejung Won Earn NIH Director’s New Innovator Awards

    The National Institutes of Health announced 93 awards to fund highly innovative, high-impact biomedical research as part of its High-Risk, High-Reward Research Program. Wesley Legant, PhD, assistant professor in the departments of pharmacology and biomedical engineering, and Hyejung Won, PhD, assistant professor of genetics, were selected as NIH Director’s New Innovator Award recipients this week. Legant … Continued

View More News

Featured Faculty

Jeremy Purvis HeadshotJeremy Purvis
Assistant Professor

Jeremy Purvis is an Assistant Professor of Genetics and Cancer Cell Biology. He was recently published in Molecular Systems Biology.

View Featured Provider

 

Leadership

Timothy Elston, PhD
Charles M. Perou, PhD

The School of Medicine has launched a new Computational Medicine Program, aiming to channel UNC’s strength in computational biology, the basic sciences, and clinical research, toward making significant advances in clinical care for patients.

Co-directors of the new program are Timothy Elston, PhD, professor of pharmacology and director of the Curriculum in Bioinformatics and Computational Biology, and Charles M. Perou, PhD, the May Goldman Shaw Distinguished Professor of Molecular Oncology at the UNC Lineberger Comprehensive Cancer Center, and professor of genetics, and of pathology and laboratory medicine.

“The Computational Medicine Program will enable teams of scientists from across the university to come together to address problems related to biomedical research,” Elston said. “Our ultimate goal is to generate models, combining many different types of data, that will enable us to predict outcomes of treatment, and design new ways of thinking about treating disease.”